• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 22 / 2013
        E.g., 1 / 22 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    President Bush Expected to Sign Product Safety Bill into Law

    August 5, 2008

    At the end of July, Congress voted overwhelmingly to adopt sweeping product safety legislation. HR 4040, Consumer Product Safety Improvement Act of 2008, bans or limits the levels of phthalates and lead in children’s products, requires third-party testing and manufacturer certification of children’s products, establishes a public consumer product safety database, provides whistleblower protections, and authorizes state attorneys general to enforce Consumer Product Safety Commission (CPSC) regulations. President Bush is expected to sign HR 4040 into law.

    Phthalates Ban, Lead Limits and General Toy Safety
    One of the most controversial measures included within HR 4040 concerns phthalates. HR 4040 permanently prohibits or bans, on an interim basis, the sale of any children’s toy or child care article containing more than 0.1 percent of certain phthalates. In addition, HR 4040 imposes stringent lead standards for products intended for children age 12 or younger.

    HR 4040 establishes the American Society for Testing and Materials Standard F963-07, Consumer Safety Specifications for Toy Safety, as an interim consumer product safety standard. It also requires third-party testing of certain children’s products prior to importation or distribution and manufacturer certification that its products comply with all applicable rules, bans and standards.

    Product Tracking and Public Database
    Within one year of enactment, manufacturers of children’s products must place distinguishing marks on their products and packaging to aid in the recall process. In addition, the legislation directs the CPSC to establish and maintain a publicly available consumer product safety database, which will contain reports from consumers, government officials, health care professionals, child service providers and public safety entities. Manufacturers and private labelers will receive advance notice of any reports that identify their products and may request redaction of only those portions that contain confidential or inaccurate information.

    State Attorneys General Enforcement and Whistleblower Protection
    Other controversial measures include authorization for state attorneys general to enforce CPSC regulations and standards and whistleblower protections. The legislation permits state attorneys general to bring actions under the CPSC’s product safety rules and regulations on behalf of their residents after first notifying the Agency.

    HR 4040 also includes a whistleblower protection that permits an employee to file a complaint within 180 days with the US secretary of labor alleging discharge or discrimination because he reported potential CPSC violations; testified or is about to testify in a proceeding concerning such violation; or objected to or refused to participate in an activity that he reasonably believed violated a CPSC order, rule, regulation or standard.

    Preemption
    HR 4040 appears to preempt states from adopting more stringent standards with respect to lead in children’s products. It is unclear, however, whether states can adopt their own testing protocols for toys.

    The full text of HR 4040 may be accessed by clicking here.

    If you have any questions about the pending legislation, please do not hesitate to contact the Arent Fox attorneys listed below.

    Georgia Ravitz
    ravitz.georgia@arentfox.com
    202.857.8939

    James R. Ravitz
    ravitz.james@arentfox.com
    202.857.8903

    Amy M. Swift
    swift.amy@arentfox.com
    202.857.6338

    Related People

    • Georgia Ravitz
    • James R. Ravitz

    Related Practices

    Consumer Product Safety
    FDA Practice (Food & Drug)

    Related Industries

    Life Sciences
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.